194 related articles for article (PubMed ID: 19273593)
1. ADAM9 is involved in pathological retinal neovascularization.
Guaiquil V; Swendeman S; Yoshida T; Chavala S; Campochiaro PA; Blobel CP
Mol Cell Biol; 2009 May; 29(10):2694-703. PubMed ID: 19273593
[TBL] [Abstract][Full Text] [Related]
2. ADAM8 is a negative regulator of retinal neovascularization and of the growth of heterotopically injected tumor cells in mice.
Guaiquil VH; Swendeman S; Zhou W; Guaiquil P; Weskamp G; Bartsch JW; Blobel CP
J Mol Med (Berl); 2010 May; 88(5):497-505. PubMed ID: 20119708
[TBL] [Abstract][Full Text] [Related]
3. Characterization of oxygen-induced retinopathy in mice carrying an inactivating point mutation in the catalytic site of ADAM15.
Maretzky T; Blobel CP; Guaiquil V
Invest Ophthalmol Vis Sci; 2014 Sep; 55(10):6774-82. PubMed ID: 25249606
[TBL] [Abstract][Full Text] [Related]
4. Antiangiogenic effect of dasatinib in murine models of oxygen-induced retinopathy and laser-induced choroidal neovascularization.
Seo S; Suh W
Mol Vis; 2017; 23():823-831. PubMed ID: 29225458
[TBL] [Abstract][Full Text] [Related]
5. Apatinib, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Suppresses Pathologic Ocular Neovascularization in Mice.
Kim KL; Suh W
Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3592-3599. PubMed ID: 28715845
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the catalytic properties of the membrane-anchored metalloproteinase ADAM9 in cell-based assays.
Maretzky T; Swendeman S; Mogollon E; Weskamp G; Sahin U; Reiss K; Blobel CP
Biochem J; 2017 Apr; 474(9):1467-1479. PubMed ID: 28264989
[TBL] [Abstract][Full Text] [Related]
7. Both Autocrine Signaling and Paracrine Signaling of HB-EGF Enhance Ocular Neovascularization.
Inoue Y; Shimazawa M; Nakamura S; Takata S; Hashimoto Y; Izawa H; Masuda T; Tsuruma K; Sakaue T; Nakayama H; Higashiyama S; Hara H
Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):174-185. PubMed ID: 29191924
[TBL] [Abstract][Full Text] [Related]
8. Pathological neovascularization is reduced by inactivation of ADAM17 in endothelial cells but not in pericytes.
Weskamp G; Mendelson K; Swendeman S; Le Gall S; Ma Y; Lyman S; Hinoki A; Eguchi S; Guaiquil V; Horiuchi K; Blobel CP
Circ Res; 2010 Mar; 106(5):932-40. PubMed ID: 20110534
[TBL] [Abstract][Full Text] [Related]
9. Pathogenic role and therapeutic potential of pleiotrophin in mouse models of ocular vascular disease.
Wang W; LeBlanc ME; Chen X; Chen P; Ji Y; Brewer M; Tian H; Spring SR; Webster KA; Li W
Angiogenesis; 2017 Nov; 20(4):479-492. PubMed ID: 28447229
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of Samul-tang on retinal neovascularization in oxygen-induced retinopathy.
Lee YM; Kim CS; Jo K; Sohn EJ; Kim JS; Kim J
BMC Complement Altern Med; 2015 Aug; 15():271. PubMed ID: 26264147
[TBL] [Abstract][Full Text] [Related]
11. TLR2 signaling contributes to the angiogenesis of oxygen-induced retinopathy.
Sun Y; Ni Y; Kong N; Huang C
Exp Eye Res; 2021 Sep; 210():108716. PubMed ID: 34352266
[TBL] [Abstract][Full Text] [Related]
12. Knockout of αA-crystallin inhibits ocular neovascularization.
Xu Q; Bai Y; Huang L; Zhou P; Yu W; Zhao M
Invest Ophthalmol Vis Sci; 2015 Jan; 56(2):816-26. PubMed ID: 25574047
[TBL] [Abstract][Full Text] [Related]
13. Implication of the hypoxia response element of the Vegf promoter in mouse models of retinal and choroidal neovascularization, but not retinal vascular development.
Vinores SA; Xiao WH; Aslam S; Shen J; Oshima Y; Nambu H; Liu H; Carmeliet P; Campochiaro PA
J Cell Physiol; 2006 Mar; 206(3):749-58. PubMed ID: 16245301
[TBL] [Abstract][Full Text] [Related]
14. Sipjeondaebo-tang, a traditional herbal formula, inhibits retinal neovascularization in a mouse model of oxygen-induced retinopathy.
Lee YM; Kim CS; Sohn E; Jo K; Lim HR; Kim SK; Kim JS; Kim J
Tohoku J Exp Med; 2014 Nov; 234(3):229-36. PubMed ID: 25365937
[TBL] [Abstract][Full Text] [Related]
15. Vascular permeability in retinopathy is regulated by VEGFR2 Y949 signaling to VE-cadherin.
Smith RO; Ninchoji T; Gordon E; André H; Dejana E; Vestweber D; Kvanta A; Claesson-Welsh L
Elife; 2020 Apr; 9():. PubMed ID: 32312382
[TBL] [Abstract][Full Text] [Related]
16. Nrf2 Activator RS9 Suppresses Pathological Ocular Angiogenesis and Hyperpermeability.
Nakamura S; Noguchi T; Inoue Y; Sakurai S; Nishinaka A; Hida Y; Masuda T; Nakagami Y; Horai N; Tsusaki H; Hara H; Shimazawa M
Invest Ophthalmol Vis Sci; 2019 May; 60(6):1943-1952. PubMed ID: 31050722
[TBL] [Abstract][Full Text] [Related]
17. M2 Macrophages Enhance Pathological Neovascularization in the Mouse Model of Oxygen-Induced Retinopathy.
Zhou Y; Yoshida S; Nakao S; Yoshimura T; Kobayashi Y; Nakama T; Kubo Y; Miyawaki K; Yamaguchi M; Ishikawa K; Oshima Y; Akashi K; Ishibashi T
Invest Ophthalmol Vis Sci; 2015 Jul; 56(8):4767-77. PubMed ID: 26218904
[TBL] [Abstract][Full Text] [Related]
18. PPARα-Dependent Effects of Palmitoylethanolamide Against Retinal Neovascularization and Fibrosis.
Ye S; Chen Q; Jiang N; Liang X; Li J; Zong R; Huang C; Qiu Y; Ma JX; Liu Z
Invest Ophthalmol Vis Sci; 2020 Apr; 61(4):15. PubMed ID: 32298438
[TBL] [Abstract][Full Text] [Related]
19. Spatial distribution of CD115
Brockmann C; Dege S; Crespo-Garcia S; Kociok N; Brockmann T; Strauß O; Joussen AM
Graefes Arch Clin Exp Ophthalmol; 2018 Feb; 256(2):313-323. PubMed ID: 29185100
[TBL] [Abstract][Full Text] [Related]
20. ADAM9 promotes lung cancer progression through vascular remodeling by VEGFA, ANGPT2, and PLAT.
Lin CY; Cho CF; Bai ST; Liu JP; Kuo TT; Wang LJ; Lin YS; Lin CC; Lai LC; Lu TP; Hsieh CY; Chu CN; Cheng DC; Sher YP
Sci Rep; 2017 Nov; 7(1):15108. PubMed ID: 29118335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
